Biofiller: blood-derived materials, evidence and uncertainties
Here, biofiller means filler-like material prepared from your own blood, not transferred fat.
Consultation information
On this page
What does biofiller mean here?
Clarify the concern and exact material. Hollowing, skin texture and pigmentation differ. Discuss previous injections, expectations and the target area; a familiar name does not replace examination or explanation of alternatives. B1F1
| Material | What it is | What is discussed | Evidence limit | Question to ask |
|---|---|---|---|---|
| PRP | Platelet-rich blood preparation | Selected skin concerns | Not the same material as plasma gel | Which preparation is proposed? A1 |
| Plasma gel | Processed blood-derived gel | Selected periorbital studies | Results depend on the studied preparation | Does the study match this method? B1 |
| HA filler | Hyaluronic acid material | Volume or contour concerns | Product and injection site matter | What are this product's limits? F1 |
The table compares material categories, not equivalent treatments. A small split-face study investigated particular preparations; it cannot establish identical composition or effects for every biofiller. Request a clear description before comparing options. B1
How do the options differ?
Compare intended benefit, uncertainty and injection risks with suitable alternatives, including postponement. A blood-derived material still requires discussion of the target tissue, preparation, added substances and follow-up. B1F1
In a study of 40 women, improvement after plasma gel and PRP was not maintained over the following three months. This limited observation does not establish a universal lifespan or justify promises of permanent rejuvenation for an unspecified preparation. B1
What should be checked before deciding?
Report medical conditions, bleeding problems, allergies, active skin inflammation and all medicines. Do not stop prescribed treatment yourself. Correct identification and sterile processing of blood matter; suitability can require postponement or further assessment rather than automatic booking. A1F1
Which risks need discussion?
Blood handling can transmit infection when unsafe. For filler-like injections, infection, nodules and vascular injury deserve discussion. General filler warnings provide a cautious safety framework; they do not establish an identical measured complication rate for plasma gel or every blood-derived preparation. A2F1
How should follow-up be planned?
Agree on written aftercare and a contact for problems. Review swelling, new lumps, persistent symptoms and the original concern before another procedure. Distinguish temporary changes from sustained benefit instead of treating every early change as success. B1F1
Questions about biofiller
Is biofiller made from fat?
Not in this description. It refers to a blood-derived material. The word biofiller alone is ambiguous, so confirm the proposed preparation; information about fat transfer should not be used as evidence for plasma gel. B1
Is plasma gel the same as PRP?
No. They involve different processing and physical properties. A comparison between them is not proof of interchangeability. Ask whether evidence concerns the exact method, the same area and the outcome you wish to assess. B1
Does my own blood make it risk-free?
No. Blood must still be handled safely. A CDC investigation of unsafe cosmetic blood procedures illustrates an infection-control failure, not the usual complication rate of biofiller. Autologous origin cannot certify the quality of a procedure. A2
Can every biofiller be dissolved like HA?
Do not assume so. Managing or removing filler depends on its material, and some removal is difficult. A plan used for hyaluronic acid cannot automatically be applied to a blood-derived gel; discuss the contingency plan before treatment. F1
Does a study prove a lasting result?
No. Short follow-up and a small study limit conclusions. Ask how lasting benefit is assessed and when to reassess rather than automatically repeat. B1